OCT 22, 2020 9:00 AM PDT

Cannabis Reduces OCD Symptoms by 50%

WRITTEN BY: Annie Lennon

Researchers from Washington State University have found that smoking cannabis can lead to a short term reduction in up to 50% of Obsessive-Compulsive Disorder (OCD) symptoms. 

Current treatments for OCD include exposure and response prevention therapy, where irrational thoughts around certain behaviors are directly challenged. Antidepressants or serotonin reuptake inhibitors (SSRI’s) are also commonly prescribed. While these treatments may relieve symptoms, however, neither are curative nor do they work in every case of OCD. 

For the study, the researchers analyzed data inputted by users of the Strainprint app who self-identified as having OCD, a condition characterized by intrusive and persistent thoughts alongside repetitive behaviors. All in all, the data logged over 1,800 cannabis sessions from 87 individuals over a period of 31 months.

From the data, the researchers found that after smoking cannabis, users who self-identified as having OCD reported a 60% reduction in their compulsions. They also reported a 49% decrease in intrusions and a 52% reduction in anxiety. In particular, the researchers found that those taking higher doses of cannabis, and strains with higher levels of cannabidiol (CBD), tended to see greater reductions in their compulsions. 

They also found, however, that as people continued to use cannabis, the associated reductions in intrusion slightly diminished, suggesting that over time users build a tolerance to the plant. Despite this, the relationship between cannabis and reductions in OCD symptoms remained fairly consistent, although symptoms were only reduced within four hours of smoking the plant. 

As such, the researchers say that their results suggest that cannabis may be beneficial in reducing symptoms of OCD in the short term. They highlight, however, that these effects do not appear to be long-term. In particular, they find the CBD findings to be of interest, as the compound is not intoxicating and thus holds the potential to enter clinical trials to modulate compulsive behavior. 

Although interesting findings, the researchers not that their inability to use a placebo control and an ‘expectancy effect’ among users may have hindered the validity of their results. Moreover, as the data came from a self-selected sample of cannabis users, and all results were self-reported, their results need more robust evidence to be conclusive. 

 

Sources: Journal of Affective DisordersNeuroscience News

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JUL 19, 2020
Cannabis Sciences
Cannabis May Relieve Pain from Sickle Cell Disease
JUL 19, 2020
Cannabis May Relieve Pain from Sickle Cell Disease
Due to the rise in opioid-associated deaths, physicians and researchers are on the constant lookout for new, healthier o ...
JUL 29, 2020
Health & Medicine
The Carrier Oil Matters When it Comes to CBD Products
JUL 29, 2020
The Carrier Oil Matters When it Comes to CBD Products
The type of oil that is used to extract and carry the medicinally active ingredients (cannabinoids and terpenes) in cann ...
AUG 04, 2020
Cannabis Sciences
Nanotechnology Makes Medicinal Cannabis More Effective
AUG 04, 2020
Nanotechnology Makes Medicinal Cannabis More Effective
It seems that cannabis can treat everything- from chronic pain to acne and maybe even cancer. But as cannabinoids are kn ...
AUG 27, 2020
Health & Medicine
Study Confirms E-cigarettes and Marijuana Not to Blame for Vaping-Related Lung Injuries
AUG 27, 2020
Study Confirms E-cigarettes and Marijuana Not to Blame for Vaping-Related Lung Injuries
A Yale School of Public Health report published August 25 2020 in the journal Addiction confirms that it was neither e-c ...
NOV 19, 2020
Health & Medicine
Two Studies Raise Cannabis Heart Concerns
NOV 19, 2020
Two Studies Raise Cannabis Heart Concerns
Cannabis was under discussion at the American Heart Association’s Scientific Sessions 2020 (held November 13&ndash ...
NOV 22, 2020
Cannabis Sciences
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
NOV 22, 2020
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
Researchers from St. Michael’s Hospital in Toronto have found that two synthetic cannabinoids available on prescri ...
Loading Comments...